ARCHIVES

Major Changes Being Considered By NCI For FCRA

This article is from The Cancer Letter archive.

Vol. 04 No. 15 | April 14, 1978

Download PDF Visit The Full Archive

Related Articles

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

Broder Encourages Support Of Drug Development Programs

March 10, 1995

NCI Seeks CRADA Partners To Develop Targets Drugs

October 24, 1997

NCI-Frederick Leases Office Building To Move Some Programs Off Army Base.

February 26, 2010

Low-Dose Tamoxifen May Be Effective In Treating Breast Cancer, Study Finds

April 25, 2003

In Brief: The Children’s Oncology Group Is Name for Pediatric Trials Groups In Merger

June 25, 1999